Oct 16, 2023 07:50AM
Dec 13, 2022 08:55AM
Aug 22, 2022 05:43AM
Aug 22, 2022 04:00AM
Aug 22, 2022 04:00AM
Mar 31, 2022 04:01PM
Mar 31, 2022 04:01PM Mereo BioPharma Reports Full Year 2021 Financial Results and Recent Highlights
Sep 7, 2021 07:35AM
Mar 31, 2021 05:02PM
Mar 31, 2021 05:02PM
Mar 24, 2021 05:00AM
Feb 11, 2021 04:05PM
Dec 18, 2020 09:22AM
Sep 29, 2020 07:00AM Mereo BioPharma Announces Interim Financial Results for the Six Months Ended June 30, 2020 and Provides Corporate Update
Jun 30, 2020 07:00AM
Jun 16, 2020 07:00AM
Mar 27, 2020 08:00AM
Feb 28, 2020 07:08AM
Feb 28, 2020 07:00AM
Feb 19, 2020 03:00AM
Feb 12, 2020 08:00AM Mereo BioPharma Announces Update on Distribution Related to Contingent Value Rights Following Recent Oncologie Licensing Agreement for Navicixizumab
Feb 10, 2020 07:00AM
Jan 14, 2020 07:03AM
Jan 14, 2020 07:00AM
Jan 13, 2020 07:00AM
Jan 13, 2020 07:00AM
Nov 11, 2019 06:30AM
Oct 7, 2019 08:02AM UPDATE: Mereo BioPharma (MREO) Receives FDA Fast Track Designation for Navicixizumab for Treatment of Heavily Pretreated Ovarian Cancer
Oct 7, 2019 08:00AM
Sep 17, 2019 07:00AM
Sep 10, 2019 08:00AM
Sep 4, 2019 08:00AM
Jul 16, 2019 08:00AM
Jul 15, 2019 08:06AM
Jul 15, 2019 08:00AM Mereo BioPharma Announces Successful Type B Meeting with U.S. FDA and Outlines Accelerated Approval Pathway for Navicixizumab in Advanced Ovarian Cancer
Jun 13, 2019 08:00AM
May 30, 2019 05:47AM
May 30, 2019 02:00AM
May 3, 2019 12:09PM
Apr 29, 2019 02:00AM
Apr 29, 2019 02:00AM
Apr 26, 2019 08:00AM Mereo Biopharma to Announce Preliminary Results for the Full Year 2018 and Host Conference Call on April 29, 2019
Apr 26, 2019 08:00AM
Apr 24, 2019 09:30AM
Apr 24, 2019 09:30AM
Jan 25, 2019 06:13AM
Dec 10, 2018 02:00AM
Dec 5, 2018 08:10AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All